Delivery Order SPE2DB20D2104-SPE2DB24FV47G

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,330.79, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has a performance period through May 12, 2023 and is a Firm Fixed Price type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,028.01 firm fixed price contract is for the supply of OPZELURA 1.5% Cream in 60 gram units, with a performance period through February 19, 2025. This order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,692.26, is for the supply of OPZELURA 1.5% Cream in 60 gram units, with a period of performance through April 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,665.65, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, to support military healthcare programs. The contract is a firm fixed-price, delivery order type, with a period of performance through January 7, 2025. No set-aside designation is mentioned. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,359.03, is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has a performance period through December 16, 2024 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,911.04, is for the delivery of OPZELURA 1.5% Cream 60GM, a pharmaceutical product. The contract has a completion date of December 19, 2024 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor for this award and the company is registered in the System for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,451.14 firm fixed-price delivery order is for the pharmaceutical product OPZELURA 1.5% CREAM 60GM. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,477.14 and a completion date of January 18, 2024. It is a delivery order contract with a firm fixed-price pricing type. The contract is for the procurement of OPZELURA 1.5% Cream, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,773.89 firm fixed price delivery order is for the supply of OPZELURA 1.5% cream in a 60 gram quantity, with a completion date of May 29, 2025. The contract is not designated as a set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a $1,793.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product OPZELURA 1.5% CREAM 60GM and has a completion date of July 29, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, supporting various defense and civilian agencies. This delivery order is issued under a larger Indefinite Delivery...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV47G
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,395.71 Firm Fixed Price contract is for the supply of OPZELURA 1.5% Cream (60g), a prescription dermatological product. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen is a long-standing supplier to the DLA Troop Support Medical program, providing a wide range of pharmaceutical and medical products to support military healthcare operations. This award is made under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA for delivering a comprehensive medical commodity portfolio. The contract does not have a set-aside designation.

Generated 10/29/24, 9:21 AM